Single-Cell Analysis Market Will Reach USD 10,304.3 Million By 2030

The single-cell analysis market  was valued at USD 3,839.0 million in 2021 and will grow at a rate of about 11.6% during 2021–2030, reaching USD 10,304.3 million by 2030, according to P&S Intelligence.

This development can be credited to the growing pace of technological improvements and the growing occurrence of cancer. the World Health Organization testified around 10 million deaths because of malignancies. Furthermore, single-cell analysis allows researchers to analyze the purposes of cells in complex tissues. Scientists in the U.S. projected that the most of single cell isolating systems can study 800 cells at a time.

Among all kinds of cells, human cells are extensively utilized for study, because of the increasing occurrence of communicable diseases among elder individuals, initiatives of governments for stem cell research, and the wide utilization of human cells in research laboratories and academic establishments.

North America is dominating the single-cell analysis market and is also projected to be in the top spot throughout the forecast period, with a value of approximately USD 5 billion.

This can be credited to the quick acceptance of progressive analytical tools, a strong healthcare system, several government subsidy agendas, and the presence of a huge number of trained experts.

The rising demand for modified medication and the increasing occurrence of communicable illnesses are the other main reasons boosting the market growth in this continent. The presence of several main players and the growing research and development spending is also ascribed to this.

The U.S. in North America holds the leading position, and it will raise with a CAGR of more than 10%, credited to the supportive repayment guidelines for healthcare services.

In 2021, the consumables category generated the highest revenue share, of approximately 70%, because of the growing need for isolation items, constant buying of reagents for research, and continuous requirement for assay kits.

A rise in the occurrence of target diseases and the constant need for different items for exosome study and isolation of the DNA and RNA are also boosting the development of this category.

The technological improvements in software tools, high-output assays, gene sequencing and microfluidics, and single-cell augmentation items and the wide availability of such items to academic institutions, healthcare settings, and diagnostic laboratories contribute to boosting sales development.

Academic and research laboratories held the highest revenue share because of the launch of spatial genomics. Furthermore, the growth of new tools and technological improvements, including the utilization of microfluidics, is boosting the industry for single-cell analysis. The development is vital because of a substantial surge in the count of research and academic labs.

Hence, the growing pace of technological improvements and the growing occurrence of cancer is the major factor driving the single-cell analysis industry.  

SOURCE: P&S Intelligence

Specialized in trend analysis segmentation and strategic recommendations to drive business growth.